Pascal may be in line for non-dilutive fundingWhen it comes to anything Covid-19 related - testing, therapeutics and vaccine - the US government has been handing out money like a drunken sailor spends it. Given its base in Seattle, Pascal would automatically qualify for US government aid for its novel cannabinoid therapy.
My guess is that our leader Dr Gray, who is affiliated with the University of Washington, has been working hard on landing support from Uncle Sam.
That would explain why the company has given no indication that a money raise is imminent.